Ethics roundtable: Using new, expensive drugs

Costly genetically engineered therapies, which threaten to cripple the health care industry economy and undermine the common good if applied indiscriminately, loom on the horizon. The spectrum of applicable candidates include moribund nursing home patients at the end of life. They will be fair game...

Descripció completa

Dades bibliogràfiques

Publicat a:	Crit Care
Autors principals:	Burrows, Richard, Crippen, David, Dellinger, R Phillip, Kelly, David F, Streat, Stephen, Whetstine, Leslie M
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2002
Matèries:	Commentary
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC153428/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12493067/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1533
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!